Olgu Sunumu
BibTex RIS Kaynak Göster

Dabigatrana bağlı özofagus ülseri

Yıl 2017, , 47 - 48, 29.08.2017
https://doi.org/10.17940/endoskopi.339868

Öz

Dabigatran trombin inhibisyonu yaparak antikoagülan etki gösteren bir ön ilaçtır. Rutin labovatuar takibi ve doz titrasyonu gerektirmemesi varfarine göre kullanım avantajı sağlanken, gastrointestinal sistem üzerine daha sık yan etki oluşturması önde gelen dezavantajlarındandır. Bizim vakamız, dabigatran kullanımına bağlı gelişen özofagus ülser hastasıdır.


Kaynakça

  • 1. Kim SH, Jeong JB, Kim JW, Koh SJ, Kim BG, Lee KL, et al. Clinical and endoscopic characteristics of drug-induced esophagitis. World journal of gastroenterology. [Multicenter Study Observational Study]. 2014 Aug 21;20(31):10994-9. 2. Bytzer P, Connolly SJ, Yang S, Ezekowitz M, Formella S, Reilly PA, et al. Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial. Clin Gastroenterol Hepatol. [Clinical Trial Research Support, Non-U.S. Gov't]. 2013 Mar;11(3):246-52 e1-5. 3. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. [Comparative Study Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2009 Sep 17;361(12):1139-51. 4. Shibagaki K, Taniguchi H, Goto D, Kobayashi K, Kinoshita Y. Dabigatran-induced asymptomatic esophageal mucosal injury. Gastrointest Endosc. [Case Reports]. 2016 Feb;83(2):472-3; discussion 4. 5. Liu E, Shehata M, Liu T, Amorn A, Cingolani E, Kannarkat V, et al. Prevention of esophageal thermal injury during radiofrequency ablation for atrial fibrillation. J Interv Card Electrophysiol. [Review]. 2012 Oct;35(1):35-44. 6. Ootani A, Hayashi Y, Miyagi Y. Dabigatran-induced esophagitis. Clin Gastroenterol Hepatol. [Case Reports]. 2014 Jul;12(7):e55-6. 7. Toya Y, Nakamura S, Tomita K, Matsuda N, Abe K, Abiko Y, et al. Dabigatran-induced esophagitis: The prevalence and endoscopic characteristics. J Gastroenterol Hepatol. 2016 Mar;31(3):610-4.

Dabigatran-induced esophageal ulcer

Yıl 2017, , 47 - 48, 29.08.2017
https://doi.org/10.17940/endoskopi.339868

Öz

Dabigatran,
which has an anticoagulant effect by inhibiting the action of thrombin, is a
prodrug. An advantage of this drug over warfarin is that it does not require
routine laboratory monitoring and dose adjustments. However, adverse effects on
the gastrointestinal system are more common in patients using dabigatran than
in patients using warfarin. In the present study, we report a case of
dabigatran-induced esophageal ulcer.

Kaynakça

  • 1. Kim SH, Jeong JB, Kim JW, Koh SJ, Kim BG, Lee KL, et al. Clinical and endoscopic characteristics of drug-induced esophagitis. World journal of gastroenterology. [Multicenter Study Observational Study]. 2014 Aug 21;20(31):10994-9. 2. Bytzer P, Connolly SJ, Yang S, Ezekowitz M, Formella S, Reilly PA, et al. Analysis of upper gastrointestinal adverse events among patients given dabigatran in the RE-LY trial. Clin Gastroenterol Hepatol. [Clinical Trial Research Support, Non-U.S. Gov't]. 2013 Mar;11(3):246-52 e1-5. 3. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. [Comparative Study Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't]. 2009 Sep 17;361(12):1139-51. 4. Shibagaki K, Taniguchi H, Goto D, Kobayashi K, Kinoshita Y. Dabigatran-induced asymptomatic esophageal mucosal injury. Gastrointest Endosc. [Case Reports]. 2016 Feb;83(2):472-3; discussion 4. 5. Liu E, Shehata M, Liu T, Amorn A, Cingolani E, Kannarkat V, et al. Prevention of esophageal thermal injury during radiofrequency ablation for atrial fibrillation. J Interv Card Electrophysiol. [Review]. 2012 Oct;35(1):35-44. 6. Ootani A, Hayashi Y, Miyagi Y. Dabigatran-induced esophagitis. Clin Gastroenterol Hepatol. [Case Reports]. 2014 Jul;12(7):e55-6. 7. Toya Y, Nakamura S, Tomita K, Matsuda N, Abe K, Abiko Y, et al. Dabigatran-induced esophagitis: The prevalence and endoscopic characteristics. J Gastroenterol Hepatol. 2016 Mar;31(3):610-4.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Sağlık Kurumları Yönetimi
Bölüm Makaleler
Yazarlar

Hakan Ümit Ünal Bu kişi benim 0000-0003-1415-0416

Özlem Saygılı Bu kişi benim 0000-0001-5618-9533

Murat Saruç 0000-0002-9541-0381

Yayımlanma Tarihi 29 Ağustos 2017
Yayımlandığı Sayı Yıl 2017

Kaynak Göster

APA Ünal, H. Ü., Saygılı, Ö., & Saruç, M. (2017). Dabigatrana bağlı özofagus ülseri. Endoskopi Gastrointestinal, 25(2), 47-48. https://doi.org/10.17940/endoskopi.339868
AMA Ünal HÜ, Saygılı Ö, Saruç M. Dabigatrana bağlı özofagus ülseri. Endoskopi Gastrointestinal. Ağustos 2017;25(2):47-48. doi:10.17940/endoskopi.339868
Chicago Ünal, Hakan Ümit, Özlem Saygılı, ve Murat Saruç. “Dabigatrana bağlı özofagus ülseri”. Endoskopi Gastrointestinal 25, sy. 2 (Ağustos 2017): 47-48. https://doi.org/10.17940/endoskopi.339868.
EndNote Ünal HÜ, Saygılı Ö, Saruç M (01 Ağustos 2017) Dabigatrana bağlı özofagus ülseri. Endoskopi Gastrointestinal 25 2 47–48.
IEEE H. Ü. Ünal, Ö. Saygılı, ve M. Saruç, “Dabigatrana bağlı özofagus ülseri”, Endoskopi Gastrointestinal, c. 25, sy. 2, ss. 47–48, 2017, doi: 10.17940/endoskopi.339868.
ISNAD Ünal, Hakan Ümit vd. “Dabigatrana bağlı özofagus ülseri”. Endoskopi Gastrointestinal 25/2 (Ağustos 2017), 47-48. https://doi.org/10.17940/endoskopi.339868.
JAMA Ünal HÜ, Saygılı Ö, Saruç M. Dabigatrana bağlı özofagus ülseri. Endoskopi Gastrointestinal. 2017;25:47–48.
MLA Ünal, Hakan Ümit vd. “Dabigatrana bağlı özofagus ülseri”. Endoskopi Gastrointestinal, c. 25, sy. 2, 2017, ss. 47-48, doi:10.17940/endoskopi.339868.
Vancouver Ünal HÜ, Saygılı Ö, Saruç M. Dabigatrana bağlı özofagus ülseri. Endoskopi Gastrointestinal. 2017;25(2):47-8.